‹

News & Bulletin UpdatesNews

Domestic Results, Capital & Corporate Actions

IndianPetroChem

This edition covers:

  • Filatex profit rises 21% even as yarn volumes shrink, putting the earnings quality test on realisations
  • Garware Hi-Tech Films posts a 30% EBITDA margin, but sustaining the record now matters more than reaching it
  • All Time Plastics raises utilisation to 65%, but a 240-basis-point gross-margin squeeze checks the volume gain
  • Rain Industries rebuilds Q2 EBITDA, but shipment timing and smelter cuts keep carbon volumes exposed
  • Navin Fluorine more than doubles Q1 profit, but the filing leaves the volume and product-mix drivers untested
  • Berger Paints grows decorative sales 13.5%, but delayed industrial pass-through keeps margin recovery uneven
  • BASF India more than doubles Q1 PAT as sales rise, but the statutory extract does not reveal the operating drivers
  • Cosmo First grows Q1 profit 26%, but Rs. 1,166 crore net debt keeps cash conversion in the foreground
  • Sanathan Textiles lifts revenue 79%, but Punjab depreciation and finance costs absorb much of the operating gain
  • Apollo Tyres rebounds to Rs. 349 crore Q1 profit, but the Enschede closure still carries an FY27 cash cost
  • Innova Rubbers expands operating margin, but high-cost funding pulls PAT margin down and customer concentration stays high
  • Kanoria’s Ethiopia textile unit returns to cash profit, but currency and inflation still frame the turnaround
  • Chemplast Sanmar holds Q1 revenue above Rs. 1,100 crore, but PVC imports and raw materials push EBITDA negative
  • Aegis gas terminals lift standalone revenue year on year, but the segment falls sharply from the March quarter
  • Primo Chemicals secures full control of Flow Tech, but the filing leaves acquisition economics and integration unquantified
  • Polyplex retains its 51% PTL stake as a tender offer buys 18.09%, preserving control while changing the minority map
  • Vardeep Petro remains in default and non-cooperative, leaving lenders with exposure but little fresh operating evidence

The complete bulletin is available to subscribers.

Read the complete bulletin

Request a free trial and our team will set up your access. Subscribers log in and return to this bulletin in full.

Questions about access? Contact our team
← Browse more news & analysis